Ge Wang

Title: Ge Wang: Innovator in Glycobiology

Introduction

Ge Wang is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of glycobiology, particularly through his innovative patents. With a total of 3 patents, his work focuses on the development of enzymes that have important applications in medical research and diagnostics.

Latest Patents

Ge Wang's latest patents include a bacterial α1,2-fucosyltransferase gene and its deduced amino acid sequence. This gene is instrumental in preparing α1,2-fucosyltransferase polypeptides and their active fragments. These polypeptides can be utilized in the production of oligosaccharides such as Lewis X, Lewis Y, Lewis B, and H type 1. These oligosaccharides are structurally similar to certain tumor-associated carbohydrate antigens found in mammals. The glycoconjugates produced from these enzymes also have significant research and diagnostic utility in developing assays to detect mammalian tumors.

Career Highlights

Ge Wang has worked at the University of Alberta, where he has contributed to various research projects and innovations. His work has been pivotal in advancing the understanding of carbohydrate structures and their implications in health and disease.

Collaborations

Ge Wang has collaborated with notable colleagues, including Diane E. Taylor and Monica Marija Palcic. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Ge Wang's contributions to glycobiology through his patents and collaborations highlight his role as an influential inventor in the field. His work not only advances scientific knowledge but also has practical applications in medical diagnostics and research.